The rapid expansion of complex biotherapeutic modalities such as RNA-based therapies is pushing conventional LC–MS workflows beyond their limits. Even though there has been great progress in ...
Cell and gene therapies present analytical challenges that conventional quality control methods were not designed to address. Advanced therapeutics require the highest resolution analytics available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results